Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ironwood Pharmaceuticals (IRWD) Return on Capital Employed (2016 - 2025)

Ironwood Pharmaceuticals' Return on Capital Employed history spans 15 years, with the latest figure at 0.1% for Q4 2025.

  • For Q4 2025, Return on Capital Employed fell 19.0% year-over-year to 0.1%; the TTM value through Dec 2025 reached 0.1%, down 19.0%, while the annual FY2025 figure was 0.11%, 14.0% down from the prior year.
  • Return on Capital Employed for Q4 2025 was 0.1% at Ironwood Pharmaceuticals, down from 0.97% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 2.46% in Q3 2024 and bottomed at 3.23% in Q3 2023.
  • The 5-year median for Return on Capital Employed is 0.23% (2022), against an average of 0.1%.
  • The largest annual shift saw Return on Capital Employed crashed -347bps in 2023 before it skyrocketed 570bps in 2024.
  • A 5-year view of Return on Capital Employed shows it stood at 0.25% in 2021, then decreased by -3bps to 0.24% in 2022, then crashed by -475bps to 0.9% in 2023, then skyrocketed by 131bps to 0.28% in 2024, then crashed by -66bps to 0.1% in 2025.
  • Per Business Quant, the three most recent readings for IRWD's Return on Capital Employed are 0.1% (Q4 2025), 0.97% (Q3 2025), and 0.72% (Q2 2025).